Pathway Capital Management, LP Verona Pharma PLC Transaction History
Pathway Capital Management, LP
- $8.69 Million
- Q1 2025
A detailed history of Pathway Capital Management, LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Pathway Capital Management, LP holds 98,329 shares of VRNA stock, worth $9.7 Million. This represents 71.82% of its overall portfolio holdings.
Number of Shares
98,329Holding current value
$9.7 Million% of portfolio
71.82%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$648 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$544 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$387 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$341 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$286 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.01B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...